Ascilion’s sampling platform extracts dISF from the skin and transports it to the sensor in your next generation wearable.
We integrate where it matters. Our platform can support virtually all sensor technologies – for instance RF, optical and electrochemical, including aptamer-based designs.
Ascilion’s unique approach unlocks new biosensing possibilities by bringing dISF out of the body. This simplifies device design, reduces development risk, and can shorten regulatory pathways – while, most importantly, enabling far greater flexibility in sensor technology.
Contact us to start a discussion with our engineering team.
Ascilion brings extensive experience from multi-year collaborations with leading global companies across industries such as medtech, wellness, cosmetics and consumer electronics.
Collaboration is a part of our DNA. In our partnerships we contribute not only our technical and product expertise, but also our understanding of the regulatory and commercialization processes.
